Found 10 results
Author Title [ Type(Desc)] Year
Filters: Author is Hu, L  [Clear All Filters]
Conference Paper
J. May, VanVeldhuisen, P., Allen, C., Hu, L., Tai, B., and Rush, A. J., Alternative Endpoints Based on Health Outcomes in Stimulant Users Trials, in 77th Annual Meeting of the College on Problems of Drug Dependence (CPDD), Phoenix, AZ, 2015.
A. Matthews, King, J., Wahle, A., Hu, L., and Shmueli-Blumberg, D., Body Mass Index and Prevalence of Obesity among Individuals with Substance Dependence, in College on Problems of Drug Dependence Sceintific Meeting, Montreal, Quebec, Canada, 2017.
A. Matthews, Hu, L., Lu, L., and Van Veldhuisen, P., Body Mass Index (BMI) and Obesity Prevalence Among Substance Abuse Participants from NIDA’s Clinical Trials Network (CTN), in College on Problems of Drug Dependence Meeting, San Diego, CA, 2013.
R. Lindblad, Hu, L., Campanella, M., Kondapaka, R., Rosa, C., Allen, C., Oden, N., and Van Veldhuisen, P., Estimating Death Rates In Substance Use Disorder, in The Society for Clinical Trials 33rd Annual Meeting, Miami, FL, 2012.
S. Sparenborg, Hu, L., Van Veldhuisen, P., Allen, C., and Tai, B., How Electronic Health Records (EHRs) Can Support Comparative Effectiveness Research (CER), in Annual Comparative Effectiveness Research Key Function Committee Meeting, Rockville, MD, 2012.
V. Veldhuisen P, Hu, L., Lindblad, R., Oden, N., Wakim, P., and Rosa, C., Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of 22 NIDA CTN Studies, in 2016 CPDD Scientific Meeting, Palm Springs, CA, 2016.
S. Sparenborg, Hu, L., J Potter, S., and Weiss, R., Pre-Existing Psychiatric Severity Did Not Affect Likelihood of Success in the Prescription Opiate Addiction Treatment Study (POATS), in College on Problems of Drug Dependence 74th Annual Meeting, Palm Springs, CA, 2012.
R. Lindblad, Saxon, A., Van Veldhuisen, P., Lu, L., Hu, L., Hasson, A., Thomas, C., Sparenborg, S., Mooney, L., and Ling, W., Safety of Combination Buprenorphine/Naloxone and Extended Release Naltrexone, in 2016 CPDD Scientific Meeting, Palm Springs, CA, 2016.